{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:52:08Z","timestamp":1776725528809,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,10]]},"DOI":"10.7759\/cureus.31335","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T18:58:25Z","timestamp":1668106705000},"source":"Crossref","is-referenced-by-count":5,"title":["Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients"],"prefix":"10.7759","author":[{"given":"Abdur","family":"Rafey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summiya","family":"Nizamuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-34-1-31","article-title":"Transfer of Streptococcus faecalis and Streptococcus faecium to the Genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov.","volume":"34","author":"Schleifer KH","year":"1984","unstructured":"Schleifer KH, Kilpper-Balz R. Transfer of Streptococcus faecalis and Streptococcus faecium to the Genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov.. Int J Syst Bacteriol. 1984, 34:31-4. 10.1099\/00207713-34-1-31","journal-title":"Int J Syst Bacteriol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-1605(03)00188-0","article-title":"Safety aspects of enterococci from the medical point of view","volume":"88","author":"Kayser FH","year":"2003","unstructured":"Kayser FH. Safety aspects of enterococci from the medical point of view. Int J Food Microbiol. 2003, 88:2-3. 10.1016\/s0168-1605(03)00188-0","journal-title":"Int J Food Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-4453(96)80003-x","article-title":"Mechanisms of glycopeptide resistance in enterococci","volume":"32","author":"Arthur M","year":"1996","unstructured":"Arthur M, Reynolds PE, Depardieu F, et al.. Mechanisms of glycopeptide resistance in enterococci. J Infect. 1996, 32:11-6. 10.1016\/s0163-4453(96)80003-x","journal-title":"J Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199611073351907","article-title":"Antimicrobial-drug resistance","volume":"335","author":"Gold HS","year":"1996","unstructured":"Gold HS, Moellering RC Jr. Antimicrobial-drug resistance. N Engl J Med. 1996, 335:1445-53. 10.1056\/NEJM199611073351907","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.01.008","article-title":"Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis","volume":"49","author":"Flokas ME","year":"2017","unstructured":"Flokas ME, Karageorgos SA, Detsis M, Alevizakos M, Mylonakis E. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017, 49:565-72. 10.1016\/j.ijantimicag.2017.01.008","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.16.1905","article-title":"Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit","volume":"163","author":"Mart\u00ednez JA","year":"2003","unstructured":"Mart\u00ednez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med. 2003, 163:1905-12. 10.1001\/archinte.163.16.1905","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-014-0678-1","article-title":"Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients","volume":"42","author":"Papadimitriou-Olivgeris M","year":"2014","unstructured":"Papadimitriou-Olivgeris M, Drougka E, Fligou F, et al.. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection. 2014, 42:1013-22. 10.1007\/s15010-014-0678-1","journal-title":"Infection"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/2047-2994-1-31","article-title":"Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study","volume":"1","author":"Karki S","year":"2012","unstructured":"Karki S, Houston L, Land G, et al.. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012, 1:31. 10.1186\/2047-2994-1-31","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/315428","article-title":"Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract","volume":"181","author":"Donskey CJ","year":"2000","unstructured":"Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis. 2000, 181:1830-3. 10.1086\/315428","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nature07250","article-title":"Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits","volume":"455","author":"Brandl K","year":"2008","unstructured":"Brandl K, Plitas G, Mihu CN, et al.. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008, 455:804-7. 10.1038\/nature07250","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01840.x","article-title":"Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci","volume":"14","author":"Sakka V","year":"2008","unstructured":"Sakka V, Tsiodras S, Galani L, et al.. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect. 2008, 14:14-21. 10.1111\/j.1469-0691.2007.01840.x","journal-title":"Clin Microbiol Infect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.11.005","article-title":"The risk factors, costs, and survival analysis of invasive VRE infections at a medical center in Eastern Taiwan","volume":"54","author":"Jiang HL","year":"2017","unstructured":"Jiang HL, Zhou Z, Wang LS, Fang Y, Li YH, Chu CI. The risk factors, costs, and survival analysis of invasive VRE infections at a medical center in Eastern Taiwan. Int J Infect Dis. 2017, 54:18-24. 10.1016\/j.ijid.2016.11.005","journal-title":"Int J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047297","article-title":"Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit","volume":"7","author":"Pan SC","year":"2012","unstructured":"Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS One. 2012, 7:e47297. 10.1371\/journal.pone.0047297","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/516112","article-title":"Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia","volume":"25","author":"Roghmann MC","year":"1997","unstructured":"Roghmann MC, McCarter RJ Jr, Brewrink J, Cross AS, Morris JG Jr. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis. 1997, 25:1056-9. 10.1086\/516112","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106463","article-title":"Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia","volume":"99","author":"Kirkizlar TA","year":"2020","unstructured":"Kirkizlar TA, Akalin H, Kirkizlar O, et al.. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia. Leuk Res. 2020, 99:106463. 10.1016\/j.leukres.2020.106463","journal-title":"Leuk Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4065\/81.4.529","article-title":"Vancomycin-resistant enterococci: colonization, infection, detection, and treatment","volume":"81","author":"Zirakzadeh A","year":"2006","unstructured":"Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc. 2006, 81:529-36. 10.4065\/81.4.529","journal-title":"Mayo Clin Proc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-012-0269-y","article-title":"Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies","volume":"40","author":"Liss BJ","year":"2012","unstructured":"Liss BJ, Vehreschild JJ, Cornely OA, et al.. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2012, 40:613-9. 10.1007\/s15010-012-0269-y","journal-title":"Infection"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.05.008","article-title":"The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients","volume":"16","author":"Kamboj M","year":"2010","unstructured":"Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA, Papanicolaou G. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010, 16:1576-81. 10.1016\/j.bbmt.2010.05.008","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2006.04.205","article-title":"Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer","volume":"34","author":"Matar MJ","year":"2006","unstructured":"Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control. 2006, 34:534-6. 10.1016\/j.ajic.2006.04.205","journal-title":"Am J Infect Control"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-018-0353-x","article-title":"Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany -\u200910\u00a0years of surveillance","volume":"7","author":"Remschmidt C","year":"2018","unstructured":"Remschmidt C, Schr\u00f6der C, Behnke M, Gastmeier P, Geffers C, Kramer TS. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany -\u200910\u00a0years of surveillance. Antimicrob Resist Infect Control. 2018, 7:54. 10.1186\/s13756-018-0353-x","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.01.078","article-title":"Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant","volume":"13","author":"Weinstock DM","year":"2007","unstructured":"Weinstock DM, Conlon M, Iovino C, et al.. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2007, 13:615-21. 10.1016\/j.bbmt.2007.01.078","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2012.077","article-title":"Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections","volume":"15","author":"Riccio LM","year":"2014","unstructured":"Riccio LM, Popovsky KA, Hranjec T, Politano AD, Rosenberger LH, Tura KC, Sawyer RG. Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections. Surg Infect (Larchmt). 2014, 15:417-24. 10.1089\/sur.2012.077","journal-title":"Surg Infect (Larchmt)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12132","article-title":"Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization","volume":"19","author":"Cheah AL","year":"2013","unstructured":"Cheah AL, Spelman T, Liew D, et al.. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013, 19:E181-9. 10.1111\/1469-0691.12132","journal-title":"Clin Microbiol Infect"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262030-00002","article-title":"Treatment options for vancomycin-resistant enterococcal infections","volume":"62","author":"Linden PK","year":"2002","unstructured":"Linden PK. Treatment options for vancomycin-resistant enterococcal infections. Drugs. 2002, 62:425-41. 10.2165\/00003495-200262030-00002","journal-title":"Drugs"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1517\/14656560902811811","article-title":"Therapeutic options for infections due to vancomycin-resistant enterococci","volume":"10","author":"Wang JL","year":"2009","unstructured":"Wang JL, Hsueh PR. Therapeutic options for infections due to vancomycin-resistant enterococci. Expert Opin Pharmacother. 2009, 10:785-96. 10.1517\/14656560902811811","journal-title":"Expert Opin Pharmacother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2011.08.014","article-title":"Single center experience of a vancomycin resistant enterococcal endocarditis cohort","volume":"63","author":"Forrest GN","year":"2011","unstructured":"Forrest GN, Arnold RS, Gammie JS, Gilliam BL. Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect. 2011, 63:420-8. 10.1016\/j.jinf.2011.08.014","journal-title":"J Infect"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1086\/516977","article-title":"High-dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multiresistant enterococci","volume":"25","author":"Dodge RA","year":"1997","unstructured":"Dodge RA, Daly JS, Davaro R, Glew RH. High-dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multiresistant enterococci. Clin Infect Dis. 1997, 25:1269-70. 10.1086\/516977","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123169-trends-of-vancomycin-resistant-enterococcus-infections-in-cancer-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:58Z","timestamp":1707507658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123169-trends-of-vancomycin-resistant-enterococcus-infections-in-cancer-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.31335","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,10]]}}}